E

Elisabetta Munzone

Istituti di Ricovero e Cura a Carattere Scientifico

ORCID: 0000-0003-3371-3878

335 papers and 8.4k citations.

PubIndex Score61Top 39% · seniorHow it's scored

335Publications

8.4kTotal Citations

First publication: 1993First senior author: 2004

Top publicationsby citations

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Massimo Cristofanilli, Klaus Pantel, Rafael Gisbert‐Criado et al.|Critical Reviews in Oncology/Hematology|2018

Cited by 268

Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, <i>ERBB2</i>–Negative Metastatic Breast Cancer

Pier Paolo Maria Berton Giachetti, Carmen Criscitiello, Stefania Morganti et al.|JAMA Network Open|2025

Cited by 11

The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “<i>indolent</i>” stage IV disease (Stage IV<sub>indolent</sub>).

Andrew A. Davis, Massimo Cristofanilli, Jean‐Yves Pierga et al.|Journal of Clinical Oncology|2018

Cited by 5

The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients

Elisabetta Munzone, Michelino De Laurentiis|Drugs & Therapy Perspectives|2023

Cited by 2

Indexing the rest of 335 publications…